NEPHROS INC - Common Stock - $0.001 par value (NEPH)
CUSIP: 640671400
Q3 2021 13F Holders as of 30 Sep 2021
- Type / Class
- Equity / Common Stock - $0.001 par value
- Shares outstanding
- 10,630,964
- Total 13F shares
- 1,700,497
- Share change
- +41,343
- Total reported value
- $14,914,000
- Price per share
- $8.77
- Number of holders
- 13
- Value change
- +$362,427
- Number of buys
- 6
- Number of sells
- 3
Quarterly Holders Quick Answers
What is CUSIP 640671400?
CUSIP 640671400 identifies NEPH - NEPHROS INC - Common Stock - $0.001 par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 640671400:
Top shareholders of NEPH - NEPHROS INC - Common Stock - $0.001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| WEXFORD CAPITAL LP |
13F
|
Company |
34%
|
3,631,197
|
$36,852,000 | — | 30 Jun 2021 | |
| Cowen Prime Advisors LLC |
13F
|
Company |
5.9%
|
626,450
|
$6,358,000 | — | 30 Jun 2021 | |
| Cowen Prime Services LLC |
13F
|
Company |
5.9%
|
626,450
|
$6,358,000 | — | 30 Jun 2021 | |
| Samjo Capital LLC |
13F
|
Company |
5.2%
|
549,100
|
$5,630,000 | — | 30 Jun 2021 | |
| BARD ASSOCIATES INC |
13F
|
Company |
2.2%
|
231,508
|
$2,350,000 | — | 30 Jun 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.94%
|
99,936
|
$1,014,000 | — | 30 Jun 2021 | |
| HighTower Advisors, LLC |
13F
|
Company |
0.52%
|
55,710
|
$565,000 | — | 30 Jun 2021 | |
| BLAIR WILLIAM & CO/IL |
13F
|
Company |
0.34%
|
36,249
|
$368,000 | — | 30 Jun 2021 | |
| Daron Evans |
3/4/5
|
CEO Specialty Renal Products |
—
mixed-class rows
|
179,718
mixed-class rows
|
$351,795 | — | 24 May 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.22%
|
23,474
|
$238,000 | — | 30 Jun 2021 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.14%
|
15,023
|
$156,000 | — | 30 Jun 2021 | |
| ELKHORN PARTNERS LIMITED PARTNERSHIP |
13F
|
Company |
0.08%
|
8,500
|
$86,000 | — | 30 Jun 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.05%
|
4,833
|
$49,000 | — | 30 Jun 2021 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.04%
|
4,569
|
$46,000 | — | 30 Jun 2021 | |
| SALEM INVESTMENT COUNSELORS INC |
13F
|
Company |
0.03%
|
3,500
|
$36,000 | — | 30 Jun 2021 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
302
|
$3,000 | — | 30 Jun 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
60
|
$1,000 | — | 30 Jun 2021 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
56
|
$1,000 | — | 30 Jun 2021 |
Institutional Holders of NEPHROS INC - Common Stock - $0.001 par value (NEPH) as of Q3 2021
As of 30 Sep 2021,
NEPHROS INC - Common Stock - $0.001 par value (NEPH) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,700,497 shares.
The largest 10 holders included
Cowen Prime Advisors LLC, Samjo Capital LLC, BARD ASSOCIATES INC, VANGUARD GROUP INC, HighTower Advisors, LLC, BLAIR WILLIAM & CO/IL, BlackRock Inc., MORGAN STANLEY, MILLENNIUM MANAGEMENT LLC, and ELKHORN PARTNERS LIMITED PARTNERSHIP.
This page lists
13
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2021 vs Q2 2021 Across Filers
Q2 2021 holders
15
Q3 2021 holders
13
Holder diff
-2
| Investor | Q2 2021 Shares | Q3 2021 Shares | Share Diff | Share Chg % | Q2 2021 Value $ | Q3 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.